StockSelector.com
  Research, Select, & Monitor Monday, September 21, 2020 2:38:43 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Albireo Pharma, Inc.$37.42($1.48)(3.80%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Albireo Pharma, Inc. has an overall rank of 7471 out of 7562 stocks based on 6 positive rankings and 10 negative rankings.

Positive Rankings
10 Day Gain
Albireo Pharma rank is 108
Estimated Revenue Growth
Albireo Pharma rank is 330
Target Prices
The average analysts' target price is $49.00 for Albireo Pharma using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Albireo Pharma is ranked 531.
90 Day Gain
Albireo Pharma rank is 1099
Debt-to-Equity
Albireo Pharma rank is 1503
Up EPS Surprise
Albireo Pharma beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
High Put/Call
Albireo Pharma has a high Put/Call ratio of 8.85 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Albireo Pharma is ranked 33.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Albireo Pharma is ranked 52.
High vPut/Call
Albireo Pharma has a high Put/Call ratio of 5.22 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Albireo Pharma is ranked 186.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Albireo Pharma is ranked 186.
Price-to-Sales
Albireo Pharma rank is 197
Negative Net Margin
Albireo Pharma rank is 239
Negative Cash Growth
Albireo Pharma rank is 468
Negative ROE
Albireo Pharma rank is 543
Negative ROA
Albireo Pharma rank is 718
Price-to-Book
Albireo Pharma rank is 984







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.